- Clinical Supervisor – Qi Integrated Health Psychedelic Assisted Therapy Program.
- Vice President of Business Development – Clearmind Medicine
- Instructor for the ATMA Psychedelic Therapy Program
- Adjunct Professor at the University of British Columbia School of Population and Public Health.
- Advisor – Psygen, manufacturer of psychedelics.
- Was Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies) for 10 years.
- Has published on the issue of drug control policy and psychedelics in the following Journals:
- Canadian Journal of Public Health
- International Journal of Drug Policy
- Encyclopaedia of Public Health
- Harm Reduction Journal
- Open Medicine
- Journal of Psychoactive Drugs
- Journal of Studies on Alcohol and Drugs
- Journal of Psychedelic Studies
- Authored the popular book: Manual for Psychedelic Guides now in its third edition.
- Obtained an MSW from UBC and a psychology BA from Queens.
- Worked for the Addiction Services for 28 years in counselling and supervisory roles.
- Has provided public education on drugs and drug policy for over 30 years.
- Worked with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs.
- Has presented in conferences and training events in many countries
- Awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.
Mark Haden is a major figure in the field of psychedelic medicines, with a long list of past and present activities and responsibilities. Among—and beyond—these, he is the Clinical Supervisor for the Psychedelic Treatment Program at Qi Integrated Health and the Vice President of Business Development at Clearmind Medicine. He is an instructor, teaching psychedelic therapy with the ATMA program and has written a book, the Manual for Psychedelic Guides (now in its third edition) which makes this information widely available.
Mark served as the Executive Director for MAPS Canada for 10 years and is an Adjunct Professor at the University of British Columbia School of Population and Public Health. Mark has published numerous articles in respected journals, has presented at conferences and training events in many countries, and was awarded the Queen’s Diamond Jubilee Medal in 2013 for drug policy reform work. Mark also has a well-deserved reputation as an exciting speaker who never fails to engage and surprise audiences.